File(s) not publicly available

NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS

conference contribution
posted on 2018-09-01, 00:00 authored by Mustafa KhasrawMustafa Khasraw, K McDonald, S Yip, R G Verhaak, A B Heimberger, M Hall, E Barnes, E Hovey, B M Ellingson, Z Lwin
NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS

History

Event

13th Meeting of the European-Association-of-Neurooncology (EANO)

Volume

20

Pagination

236 - 236

Publisher

OXFORD UNIV PRESS INC

Location

Stockholm, SWEDEN

Start date

2018-10-10

End date

2018-10-14

ISSN

1522-8517

eISSN

1523-5866

Language

English

Publication classification

E3 Extract of paper

Title of proceedings

NEURO-ONCOLOGY